SKI Market

A+| A| A-|

Indian Indices

Sensex

75,183.36 -135.03
( -0.18%)

Global Indices

Nasdaq

50,030.26 645.37
(1.31%)

Dow Jones

7,453.29 78.68
(1.07%)

Hang Seng

61,747.25 1,942.84
(3.25%)

Nikkei 225

10,466.07 33.73
(0.32%)

Forex

USD-INR

96.52 0.30
(0.32%)

EUR-INR

112.16 0.19
(0.17%)

GBP-INR

129.37 0.68
(0.52%)

JPY-INR

0.61 0.00
(0.22%)

YOU ARE HERE :
HOME
Markets
Equity
Corporate Results - Detailed News

EQUITY - MARKET SCREENER

Back

Windlas Biotech consolidated net profit declines 1.78% in the March 2026 quarter

21-May-26 18:03 Hrs IST

Net profit of Windlas Biotech declined 1.78% to Rs 15.99 crore in the quarter ended March 2026 as against Rs 16.28 crore during the previous quarter ended March 2025. Sales rose 17.66% to Rs 238.50 crore in the quarter ended March 2026 as against Rs 202.71 crore during the previous quarter ended March 2025.

For the full year,net profit rose 8.97% to Rs 66.46 crore in the year ended March 2026 as against Rs 60.99 crore during the previous year ended March 2025. Sales rose 18.98% to Rs 904.09 crore in the year ended March 2026 as against Rs 759.88 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	238.50	202.71	18	904.09	759.88	19
OPM %	10.60	12.60	-	11.59	12.38	-
PBDT	28.16	29.16	-3	117.72	107.74	9
PBT	20.16	20.82	-3	86.98	79.76	9
NP	15.99	16.28	-2	66.46	60.99	9

75,183.36 -135.03 ( -0.18%)

50,030.26 645.37 (1.31%)

7,453.29 78.68 (1.07%)

61,747.25 1,942.84 (3.25%)

10,466.07 33.73 (0.32%)

96.52 0.30 (0.32%)

112.16 0.19 (0.17%)

129.37 0.68 (0.52%)

0.61 0.00 (0.22%)